Psyrx Bio-Tech (PSRX) Income Statement
Psyrx Bio-Tech Income Statement
Last quarter (Q2 2026), Psyrx Bio-Tech's total revenue was $0.00, an increase of 100.00% from the same quarter last year. In Q2, Psyrx Bio-Tech's net income was $-273.71K. See Psyrx Bio-Tech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ -30.46K | $ 337.64K | $ 404.76K | $ 49.17K | |
| $ -1.57K | $ -882.90K | $ -348.17K | $ -195.13K | $ -261.91K | |
| $ 748.17K | $ 1.58M | $ 4.26M | $ 8.36M | $ 9.12M | |
| Depreciation and Amortization | $ 1.57K | $ 229.71K | $ 361.46K | $ 339.52K | $ 253.24K |
| $ -748.17K | $ -2.09M | $ -4.10M | $ -8.22M | $ -9.13M | |
| $ -749.74K | $ -2.46M | $ -4.60M | $ -8.56M | $ -9.38M | |
| $ -2.23M | $ 141.07K | $ 141.26K | $ -22.91K | $ -97.69K | |
| $ -2.98M | $ -2.32M | $ -4.46M | $ -8.58M | $ -9.48M | |
| $ -2.98M | $ -2.32M | $ -4.47M | $ -8.59M | $ -9.49M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.61 | $ -7.98 | $ -21.31 | $ -44.58 | $ -64.21 |
| Diluted EPS | $ -0.61 | $ -7.98 | $ -21.31 | $ -44.58 | $ -64.21 |
| Weighted Average Shares Outstanding | 4.89M | 290.86K | 209.54K | 192.62K | 147.81K |
| Weighted Average Shares Outstanding (Diluted) | 4.89M | 290.86K | 209.54K | 192.62K | 147.81K |
Currency in USD
